Sale!

FGG Gene Afibrinogenemia congenital Genetic Test

Name: FGG Gene Afibrinogenemia congenital Genetic Test
SKU: TEST-3852
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FGG Gene Afibrinogenemia Congenital Genetic Test is a specialized diagnostic procedure designed to identify mutations in the FGG gene, which are responsible for congenital afibrinogenemia. Congenital afibrinogenemia is a rare genetic disorder characterized by the complete absence of fibrinogen, a protein essential for blood clotting. This condition can lead to severe bleeding complications from an early age. The test involves analyzing the patient’s DNA to detect any genetic alterations in the FGG gene that could lead to the disorder.

This test is particularly important for individuals with a family history of bleeding disorders or for those who have experienced unexplained bleeding episodes. Early diagnosis through genetic testing can facilitate timely management and treatment strategies, potentially reducing the risk of severe bleeding events.

The FGG Gene Afibrinogenemia Congenital Genetic Test is available at DNA Labs UAE, a leading facility in genetic diagnostics. The test is priced at 4400 AED. DNA Labs UAE employs cutting-edge technology and highly skilled professionals to ensure accurate and reliable results, providing essential information for the management of congenital afibrinogenemia and related bleeding disorders.

Description

FGG Gene Afibrinogenemia congenital Genetic Test

Test Name: FGG Gene Afibrinogenemia congenital Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Hematology

Doctor: Hematologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for FGG Gene Afibrinogenemia, congenital NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGG Gene Afibrinogenemia, congenital NGS Genetic DNA Test gene FGG

Test Details: FGG gene afibrinogenemia is a rare genetic disorder characterized by a deficiency or complete absence of fibrinogen, a protein necessary for blood clotting. This condition is caused by mutations in the FGG gene, which provides instructions for making one of the three subunits of fibrinogen.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the detection of genetic mutations associated with various disorders. In the case of FGG gene afibrinogenemia, NGS genetic testing can be used to identify specific mutations within the FGG gene that are responsible for the condition.

NGS genetic testing involves the sequencing of DNA or RNA samples obtained from the individual being tested. This sequencing technique can provide a comprehensive analysis of the genetic material, allowing for the identification of mutations or variants in the FGG gene that may be causing afibrinogenemia.

By performing NGS genetic testing for FGG gene afibrinogenemia, healthcare professionals can provide a definitive diagnosis for individuals suspected of having this condition. This can help guide appropriate treatment strategies and provide important information for genetic counseling and family planning.

Test Name	FGG Gene Afibrinogenemia congenital Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Hematology
Doctor	Hematologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for FGG Gene Afibrinogenemia, congenital NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGG Gene Afibrinogenemia, congenital NGS Genetic DNA Test gene FGG
Test Details	FGG gene afibrinogenemia is a rare genetic disorder characterized by a deficiency or complete absence of fibrinogen, a protein necessary for blood clotting. This condition is caused by mutations in the FGG gene, which provides instructions for making one of the three subunits of fibrinogen. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the detection of genetic mutations associated with various disorders. In the case of FGG gene afibrinogenemia, NGS genetic testing can be used to identify specific mutations within the FGG gene that are responsible for the condition. NGS genetic testing involves the sequencing of DNA or RNA samples obtained from the individual being tested. This sequencing technique can provide a comprehensive analysis of the genetic material, allowing for the identification of mutations or variants in the FGG gene that may be causing afibrinogenemia. By performing NGS genetic testing for FGG gene afibrinogenemia, healthcare professionals can provide a definitive diagnosis for individuals suspected of having this condition. This can help guide appropriate treatment strategies and provide important information for genetic counseling and family planning.